These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16870350)

  • 21. How to screen for problematic cannabis use in population surveys: an evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss sample of adolescents and young adults.
    Annaheim B; Rehm J; Gmel G
    Eur Addict Res; 2008; 14(4):190-7. PubMed ID: 18583916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Validation of the Turkish version of the mood disorder questionnaire for screening bipolar disorders].
    Konuk N; Kiran S; Tamam L; Karaahmet E; Aydin H; Atik L
    Turk Psikiyatri Derg; 2007; 18(2):147-54. PubMed ID: 17566880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic approach to identifying drug-seeking patients.
    Pretorius RW; Zurick GM
    Fam Pract Manag; 2008 Apr; 15(4):A3-5. PubMed ID: 18444310
    [No Abstract]   [Full Text] [Related]  

  • 26. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.
    Yudko E; Lozhkina O; Fouts A
    J Subst Abuse Treat; 2007 Mar; 32(2):189-98. PubMed ID: 17306727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Validation for Colombia of the CRAFFT substance abuse screening test in adolescents].
    Cote-Menendez M; Uribe-Isaza MM; Prieto-Suárez E
    Rev Salud Publica (Bogota); 2013; 15(2):220-32. PubMed ID: 24892665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening psychiatric patients for illicit drug use disorders and problems.
    Tiet QQ; Finney JW; Moos RH
    Clin Psychol Rev; 2008 Apr; 28(4):578-91. PubMed ID: 17900773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.
    Knight JR; Sherritt L; Shrier LA; Harris SK; Chang G
    Arch Pediatr Adolesc Med; 2002 Jun; 156(6):607-14. PubMed ID: 12038895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS).
    Grassi L; Sabato S; Rossi E; Marmai L; Biancosino B
    J Affect Disord; 2009 Apr; 114(1-3):193-9. PubMed ID: 18757101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on short-term therapeutic effect and its impact factors of stereotactic surgery for treating opiate users with opiate dependence in Sichuan].
    Zhang B; Liao J; Wang ZR; Chen Y; Gu JW; Chen LG; Fang J
    Wei Sheng Yan Jiu; 2006 Sep; 35(5):599-603. PubMed ID: 17086714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users.
    Seignourel PJ; Green C; Schmitz JM
    Drug Alcohol Depend; 2008 Mar; 93(3):271-8. PubMed ID: 18093749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying injection drug users at risk of nonfatal overdose.
    Coffin PO; Tracy M; Bucciarelli A; Ompad D; Vlahov D; Galea S
    Acad Emerg Med; 2007 Jul; 14(7):616-23. PubMed ID: 17554010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Children's Automatic Thoughts Scale in a clinical sample: psychometric properties and clinical utility.
    Schniering CA; Lyneham HJ
    Behav Res Ther; 2007 Aug; 45(8):1931-40. PubMed ID: 17078927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AUDIT-C as a brief screen for alcohol misuse in primary care.
    Bradley KA; DeBenedetti AF; Volk RJ; Williams EC; Frank D; Kivlahan DR
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1208-17. PubMed ID: 17451397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The substances and choices scale (SACS)--the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people.
    Christie G; Marsh R; Sheridan J; Wheeler A; Suaalii-Sauni T; Black S; Butler R
    Addiction; 2007 Sep; 102(9):1390-8. PubMed ID: 17645425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.